CARLSBAD, Calif.--(BUSINESS WIRE)--March 6, 2006--Invitrogen Corporation (Nasdaq:IVGN), a provider of essential life science products and services that support disease research and drug discovery, today announced a collaboration with the NIH Chemical Genomics Center (NCGC). The goal of the collaboration is to identify novel small molecules that modulate key signaling pathways associated with disease pathophysiology.
